Entry Detail



General Information

Database ID:LDA0000755
Species:Homo sapiens
Confidence Score:0.5483
Contents:>> ncRNA Information
>> Regulatory Relationship
>> Disease Information
>> Evidence Support
>> Reference

 

ncRNA Information

ncRNA Symbol:FBXL19-AS1
Full Name:FBXL19 antisense RNA 1 (head to head)
Category:lncRNA
Species:Homo sapiens
Synonyms:MGC125469//MGC125470//MGC125472
Chromosome:16
Strand:-
Coordinate:
Start Site(bp):30919319End Site(bp):30923269
Gene Summary:N/A
External Links:
Ensembl ID:ENSG00000260852
HGNC ID:HGNC:27557
Entrez Gene:283932
VEGA ID:OTTHUMG00000176767
UCSC ID:uc002dzy.4
ENA:AK090544
RefSeq Accession:NR_024348
UniProtKB:Q494R0

 

Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
BCL7C
16
30833626
30894960
-
CTF1
16
30896607
30903560
+
FBXL19
16
30923055
30948783
+
ORAI3
16
30949066
30956461
+
SETD1A
16
30957294
30984664
+
HSD3B7
16
30985207
30989152
+
STX1B
16
30989256
31010661
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
MIR4519
16
30875266
30875323
-
MIR762
16
30893903
30893985
+
Display:

 

Disease Information

 Disease OntologyMeSH
Disease ID:DOID:3069D001254
Disease Name:astrocytomaAstrocytoma
Category:Disease OntologyMeSH
Type:disease of cellular proliferationNeoplasms
Define:A malignant glioma that is has_material_basis_in astocyte cells, a type of star-shaped glial cell, located_in the cerebrum.Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
Alias:Astrocytic tumor//astrocytoma of brain (disorder)//astrocytoma of Cerebrum//astrocytoma, no ICD-O subtype (morphologic abnormality)//astroglioma//cerebral astrocytomaAstrocytomas//Astroglioma//Astrogliomas//Glioma, Astrocytic//Astrocytic Glioma//Astrocytic Gliomas//Gliomas, Astrocytic//Astrocytoma, Grade I//Astrocytomas, Grade I//Grade I Astrocytoma//Grade I Astrocytomas//Astrocytoma, Grade II//Astrocytomas, Grade II//Grade II Astrocytoma//Grade II Astrocytomas//Astrocytoma, Protoplasmic//Astrocytomas, Protoplasmic//Protoplasmic Astrocytoma//Protoplasmic Astrocytomas//Astrocytoma, Subependymal Giant Cell//Subependymal Giant Cell Astrocytoma//Pilocytic Astrocytoma//Astrocytoma, Pilocytic//Astrocytomas, Pilocytic//Pilocytic Astrocytomas//Childhood Cerebral Astrocytoma//Astrocytoma, Childhood Cerebral//Astrocytomas, Childhood Cerebral//Cerebral Astrocytoma, Childhood//Cerebral Astrocytomas, Childhood//Childhood Cerebral Astrocytomas//Fibrillary Astrocytoma//Astrocytoma, Fibrillary//Astrocytomas, Fibrillary//Fibrillary Astrocytomas//Gemistocytic Astrocytoma//Astrocytoma, Gemistocytic//Astrocytomas, Gemistocytic//Gemistocytic Astrocytomas//Intracranial Astrocytoma//Astrocytoma, Intracranial//Astrocytomas, Intracranial//Intracranial Astrocytomas//Juvenile Pilocytic Astrocytoma//Astrocytoma, Juvenile Pilocytic//Astrocytomas, Juvenile Pilocytic//Juvenile Pilocytic Astrocytomas//Pilocytic Astrocytoma, Juvenile//Pilocytic Astrocytomas, Juvenile//Oligoastrocytoma, Mixed//Mixed Oligoastrocytoma//Mixed Oligoastrocytomas//Oligoastrocytomas, Mixed//Anaplastic Astrocytoma//Anaplastic Astrocytomas//Astrocytoma, Anaplastic//Astrocytomas, Anaplastic//Astrocytoma, Grade III//Astrocytomas, Grade III//Grade III Astrocytoma//Grade III Astrocytomas//Cerebral Astrocytoma//Astrocytoma, Cerebral//Astrocytomas, Cerebral//Cerebral Astrocytomas

 

Evidence Support

Strong Evidence:N/A
Weak Evidence:Microarray
Prediction Method:N/A

 

Reference

[1] PubMed ID:26252651
Disease Name:astrocytoma
Sample:brain
Dysfunction Pattern:Regulation [down-regulated]
Validated Method:Microarray
Description:Among the lncRNAs detected,3806 lncRNAs with a fold change>2 or <0.5 and a q value<0.05 were found to have significantly different expression levels in astrocytoma samples compared to NAT samples. Of those,1196 were downregulated and 2610 were upregulated.
Author:Zhi F,Wang Q,Xue L,Shao N,Wang R,Deng D,Wang S,Xia X,Yang Y
Year:2015
Title:The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
Causality:No